John B Henneman Iii Anika Therapeutics, Inc. (ANIK) insider trading activity
John B Henneman Iii is Director of Anika Therapeutics, Inc.. Currently has a direct ownership of 35,707 shares of ANIK, which is worth approximately $605,947. The most recent transaction as insider was on Jul 09, 2024, when has been sold 5,771 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
35.7K
0%
3M change
19.28%
12M change
Total Value Held
$605,947
JOHN B HENNEMAN III Transaction History
Also insider at
JBH
John B Henneman Iii
Director
Boston, MA